Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization

Academic Article
uri icon

publication date

  • September 2003

abstract

  • The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.